A Multicenter, Randomized, Parallel, Two-period, Non-inferiority Study of EurofarmavsAlenia in Asthma and COPD Treatment

NCT04233190 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

472

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma Copd

Interventions

DRUG: Alenia® 12mcg + 400mcg / Alenia® 6mcg + 200mcg

Sponsor

Eurofarma Laboratorios S.A.